Gerrit Dispersyn
Insider
First SEC filing: June 26, 2017 · Latest: June 26, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 1, 2022 | PHIO | F | 8,954 | $0.82 | $7,342 | 212,327 Direct | -4.05% | Disposed | -98.9% (price as of 2026-10-06) |
| Feb. 15, 2022 | PHIO | A | 126,000 | · | · | 221,281 Direct | +132.24% | Acquired | (price as of 2026-10-06) |
| Aug. 16, 2021 | PHIO | P | 6,000 | $1.63 | $9,780 | 95,281 Direct | +6.72% | Acquired | -99.4% (price as of 2026-10-06) |
| March 4, 2021 | PHIO | P | 1,953 | $2.56 | $5,000 | 89,281 Direct | +2.24% | Acquired | -99.6% (price as of 2026-10-06) |
| March 3, 2021 | PHIO | P | 2,500 | $3.03 | $7,575 | 87,328 Direct | +2.95% | Acquired | -99.7% (price as of 2026-10-06) |
| March 1, 2021 | PHIO | A | 68,450 | · | · | 84,828 Direct | +417.94% | Acquired | (price as of 2026-10-06) |
| Aug. 19, 2020 | PHIO | P | 2,000 | $2.50 | $5,000 | 16,377 Direct | +13.91% | Acquired | -99.6% (price as of 2026-10-06) |
| March 1, 2020 | PHIO | F | 673 | $2.93 | $1,972 | 14,628 Direct | -4.40% | Disposed | -99.7% (price as of 2026-10-06) |
| Nov. 18, 2019 | PHIO | A | 350,000 | $0.10 | $35,000 | 827,817 Direct | +73.25% | Acquired | -99.8% (price as of 2026-10-06) |
| Aug. 1, 2019 | PHIO | F | 1,236 | $0.40 | $494 | 477,817 Direct | -0.26% | Disposed | -100.0% (price as of 2026-10-06) |
| March 1, 2019 | PHIO | A | 407,703 | · | · | 479,053 Direct | +571.41% | Acquired | (price as of 2026-10-06) |
| Feb. 13, 2019 | PHIO | A | 55,000 | · | · | 71,350 Direct | +336.39% | Acquired | (price as of 2026-10-06) |
| Aug. 1, 2018 | PHIO | A | 16,000 | · | · | 16,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 1, 2018 | PHIO | A | 16,000 | · | · | 16,350 Direct | +4571.43% | Acquired | (price as of 2026-10-06) |
| June 23, 2017 | PHIO | P | 3,500 | $0.62 | $2,170 | 3,500 Direct | · | Acquired | -100.0% (price as of 2026-10-06) |
| April 24, 2017 | PHIO | A | 95,000 | · | · | 95,000 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 1, 2018 | PHIO | Stock option (right to buy) | Common stock | $1.79 | Aug. 1, 2028 | 16,000 | Acquired |
| April 24, 2017 | PHIO | Stock option (right to buy) | Common stock | $0.65 | April 24, 2027 | 95,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $178,514 | · | · | · | · | · | $202,744 | $489,769 |
| 2017 | $186,346 | · | · | · | · | · | $275 | $231,176 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.